BLGO Financial Facts
Loss from operations: -1.23MGross Margin: 115.21K
See Full Income Statement
Accumulated Deficit: -89.68M
Additional Paid-In Capital: 88.93M
See Full Balance Sheet
BioLargo, Inc. (BLGO) Earnings
|
Expand Research on BLGO
| Next EPS Date | 8/17/26 *Est. | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | 0.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | 0.0% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/20/26  |
Q126 | N/A | -$0.01 | N/A | N/A | $1.1M | N/A | N/A | N/A | ||
| 4/6/26 |
Q425 | N/A | -$0.01 | N/A | N/A | $1.2M | N/A | N/A | N/A | ||
| 11/17/25 |
Q325 | N/A | -$0.01 | N/A | N/A | $4.1M | N/A | N/A | N/A | ||
| 11/13/25 |
Q325 | N/A | -$0.01 | N/A | N/A | $4.1M | N/A | N/A | N/A | ||
| 11/12/25 |
Q325 | N/A | -$0.01 | N/A | N/A | $4.1M | N/A | N/A | N/A | ||
| 8/15/25 |
Q225 | N/A | $0.00 | N/A | N/A | $4M | N/A | N/A | N/A | ||
| 5/15/25 |
Q125 | N/A | $0.00 | N/A | N/A | $5.6M | N/A | N/A | N/A | ||
| 5/14/25 |
Q125 | N/A | $0.00 | N/A | N/A | $5.6M | N/A | N/A | N/A |
